ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

JPMorgan Shifts Millions Across Asian Holdings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The most recent insider filing data, dated 8 September 2026, shows JPMorgan Chase making notable moves across several Hong Kong-listed stocks. The bank filed disclosures showing it cut its stake in Kingdee International Software Group (268) by $84.9 million. It also sold $70.8 million worth of shares in Sunny Optical Technology (2382). Both trades were executed on 2 September.

JPMorgan moved in the opposite direction on Huaneng Power International (902), buying $26.9 million of shares on the same date. The buy brings the bank's position in the Chinese power utility higher, though as a 5% owner the move reflects portfolio management rather than a classic C-level conviction buy.

Outside Hong Kong, the chairman of Turkish industrial firm Burçelik Vana (BURVA) bought $12.9 million of stock on 7 September. That is a discretionary purchase by the company's top executive, which carries stronger signal than an institutional reshuffle.

A private equity firm, PENM IV Germany, filed a $23.2 million sale in Vietnamese airport services company Taseco Air Services on 7 September.

Note: ORTEX's first-party SEC EDGAR Form 4 tables were not accessible in this environment, so US open-market insider trades and Schedule 13D activist filings could not be retrieved. The vendor insider dataset's most recent filing date is 8 September 2026, meaning trades filed after that date are not reflected here.

Stocks in this article

How this article was generated

Generated
6 Nov 2026, 04:12
Prompt version
v1.0
Data sources
Institutional positioningAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.